Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
about
Current systemic treatment of hepatocellular carcinoma: A review of the literatureIntraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumorsTransarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.Molecular-genetic imaging of cancer.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Gene Therapies for Cancer: Strategies, Challenges and Successes.Targeting telomerase for cancer therapeuticsViruses as anticancer drugs.Use of the Rad51 promoter for targeted anti-cancer therapyAdenoviral vector-based strategies for cancer therapy.Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.Clinical development directions in oncolytic viral therapy.Recent advances in oncolytic virus design.Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.Advances in adenovirus-mediated p53 cancer gene therapy.Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.p53 Replacement Therapy for Cancer.Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice.A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.Oncolytic adenovirus based on serotype 3.
P2860
Q27026036-E3F62031-9815-4BC4-A02F-B7A5180FBCEAQ33710438-09FF61FB-F001-4FFC-8639-5709DBC5268CQ33730735-4645D681-02AC-41B7-83FE-9C3929A5158EQ33919629-2E85DEB1-23E6-4A0C-846A-89DA9614DA64Q34415371-CACF2F80-4864-4EDE-8C7B-9BC4F7D79945Q35116121-BB8FEEFD-A3D1-4296-8DBD-A7FF3011CF2FQ35142325-27211C25-E614-4191-82EA-006B3E43752CQ35186312-0305DC3B-529A-4F56-8CD4-88D239BE47BDQ36484571-5CE24D9C-91E2-492D-88A3-80F8092653CBQ36850878-FFA72678-9C0C-480F-A841-D7BB29CF4D0CQ37081622-13F9D246-573A-4575-9AB2-8DADE8707D07Q37409025-76CE69E9-02B0-4EDC-B685-FB92D957388DQ37728937-4BABED13-C09B-45BE-A2EA-6347DE7DAF81Q37857659-4F3535BB-FBFE-4642-8C06-46EC4DECCE77Q37865172-B0C2B61C-3E32-4F2A-A5B9-B66D07744F12Q37866781-36A4850A-2219-43C3-A2C7-6456DD7E68B6Q38150910-1DA1325B-4F2C-47BC-96BA-8393C1D78849Q38875030-A309F5D5-9F39-47A8-9EBD-1E7DA660104FQ39094425-70E9558F-0AEB-4E60-A176-DEBB08F63CD9Q39298850-CBB9B56B-9571-4929-B76B-07AA3D97BC1CQ39413029-4F67858A-3405-4796-8E0B-0BF3FE31451BQ39616158-1488B387-4770-49F8-B573-83FAA6F2A8AF
P2860
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
@en
type
label
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
@en
prefLabel
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
@en
P2093
P1476
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
@en
P2093
Noriaki Tanaka
Toshiyoshi Fujiwara
Yasuo Urata
P304
P356
10.2174/156800907780058835
P577
2007-03-01T00:00:00Z